Antagonistic effect of aclarubicin on camptothecin induced cytotoxicity: Role of topoisomerase I
- 1 June 1994
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 47 (11), 2105-2110
- https://doi.org/10.1016/0006-2952(94)90087-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Different modes of anthracycline interaction with topoisomerase II: Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistanceBiochemical Pharmacology, 1993
- Mode of action of topoisomerase II-targeting agents at a specific DNA sequence: Uncoupling the DNA binding, cleavage and religation eventsJournal of Molecular Biology, 1992
- Principles and practice of DNA filter elutionPharmacology & Therapeutics, 1991
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complexBiochemistry, 1989
- Inhibition of type II topoisomerase by fostriecinBiochemical Pharmacology, 1988
- Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavageJournal of Molecular Biology, 1988
- DNA topoisomerase II: A primer on the enzyme and its unique role as a multidrug target in cancer chemotherapyPharmacology & Therapeutics, 1987
- Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavageBiochemical Pharmacology, 1985
- Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase IIScience, 1984